|
Canada-0-MIDWIVES företaget Kataloger
|
Företag Nyheter:
- Antiphospholipid syndrome in pregnancy: a comprehensive literature . . .
This review provides a comprehensive synthesis of current knowledge on the impact of antiphospholipid syndrome in pregnancy, emphasizing its role in adverse obstetric outcomes, such as recurrent pregnancy loss, preeclampsia, and intrauterine growth restriction
- Management and outcomes of women with antiphospholipid syndrome during . . .
Women with antiphospholipid syndrome (APS) have an increased risk of adverse pregnancy outcomes To define clinical, serologic, and treatment factors that can predict outcomes in pregnant women with APS
- Antiphospholipid syndrome in pregnancy: a comprehensive literature . . .
APS remains a critical determinant of adverse pregnancy outcomes, necessitating precise diagnostic criteria and tailored management approaches
- Pregnancy outcomes in patients with primary antiphospholipid syndrome . . .
Adverse maternal outcomes observed in pregnant women with antiphospholipid syndrome (Part II) APS = antiphospholipid syndrome, CI = confidence interval Fetal outcomes were also assessed in this analysis
- Factors associated with adverse pregnancy outcomes in women with . . .
Positive tests for two or more anti-phospholipid antibodies and low complements were associated with adverse pregnancy outcomes These results have important implications for clinicians 1 Introduction
- Antiphospholipid syndrome: An update on risk factors for pregnancy outcome
The early identification of risk factors associated with poor pregnancy outcome could be the optimal strategy to establish criteria for additional therapies, such as hydroxychloroquine, steroids, intravenous immunoglobulin, and plasma exchange
- Management and outcomes of women with antiphospholipid syndrome during . . .
Women with antiphospholipid syndrome (APS) have an increased risk of adverse pregnancy outcomes To define clinical, serologic, and treatment factors that can predict outcomes in pregnant women with APS Retrospective cohort study of pregnant women with APS evaluated at a university medical center between January 2006 and August 2021
- Antiphospholipid syndrome characteristics and adverse pregnancy . . .
Primary composite outcomes were rated as severe (stillbirth, fetal growth restriction at <34 weeks, severe pre-eclampsia, or delivery at <32 weeks) and mild (stillbirth, any fetal growth restriction, any pre-eclampsia, or delivery at <34 weeks) A total of 99 women were included in the analysis
- Pregnancy Management in Women with Antiphospholidic Syndrome
Antiphospholipid syndrome is associated with pregnancy complications such as recurrent early fetal loss, fetal death, preeclampsia (PE), and fetal growth restriction (FGR) Although autoimmune disorders may have serious implication during pregnancy important advancements in pregnancy outcome have been reported in women with APL
- Pregnancy outcome predictors in antiphospholipid syndrome: A systematic . . .
The results of this meta-analysis identified previous thrombosis, laboratory category I, triple positivity and lupus anticoagulant positivity as the most important predictors of adverse pregnancy outcomes This up-to-date knowledge, can be used in preconception counseling and tailoring of obstetric …
|
|